로켓 파마슈티컬스, Inc.
US ˙ NasdaqGM ˙ US77313F1066

SecurityRCKT / Rocket Pharmaceuticals, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership217,851 shares
Latest Disclosed Value $ 779,906
Creative Planning reports 30.42% increase in ownership of RCKT / Rocket Pharmaceuticals, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 217,851 shares of Rocket Pharmaceuticals, Inc. (US:RCKT) valued at $779,907 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 167,039 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 30.42% during the quarter. The current value of the position is $599,090 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 217,851 50,812 30.42 780 32.94 0.0005
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 167,039 12,054 7.78 586 16.04 0.0004
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 154,985 111,514 256.53 505 376.42 0.0004
2025-08-08 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 43,471 -36,130 -45.39 107 -80.00 0.0001
2025-05-15 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 79,601 -9,243 -10.40 531 -52.51 0.0005
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 88,844 88,844 1,117 0.0011
2017-07-12 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -2,000 -100.00 0 -100.00
2017-04-07 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 2,000 0 0.00 4 -66.67 0.0000
2017-01-09 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 2,000 -3,000 -60.00 12 -74.47 0.0001
2016-10-12 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 5,000 5,000 47 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.